相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monoclonal Antibodies for Migraine Prevention Progress, but Not a Panacea
Elizabeth W. Loder et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Telcagepant-almost gone, but not to be forgotten (invited editorial related to Ho etal., 2015)
P. Christopher H. Gottschalk
CEPHALALGIA (2016)
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Tiffini Voss et al.
CEPHALALGIA (2016)
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
Sander Greenland et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2016)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)
Simon R. Sinclair et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine
Paul L. Durham et al.
CNS DRUGS (2010)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Eletriptan - A review of its use in the acute treatment of migraine
Paul L. McCormack et al.
DRUGS (2006)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
分享论文
